All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
| Status | Trial ID | Title | Completion date | Category |
|---|---|---|---|---|
| Reported results Terminated | 2006-004088-77 | Doxorubicin-Transdrug® in Advanced HepatoCellular Carcinoma A Randomized, Multicenter Phase 2-3 Study. | 2011-06-27 | due-trials |
| Reported results | 2006-005788-24 | A Randomised, Double-Blind, Single dose, One-Day Early Administration, Multicentre Study comparing the Efficacy and Safety of Acyclovir Lauriad 50 mg muco-adhesive buccal tablet to matching Placebo, i... | 2009-09-04 | due-trials |
| Reported results | 2009-014870-16 | A phase II, multicentre, randomised, double-blind, placebo-controlled study comparing the efficacy and safety of Clonidine Lauriad™ 50 μg and 100 μg mucoadhesive buccal tablet (MBT) applied once daily... | 2014-08-20 | due-trials |
| Reported results | 2011-002843-92 | Multicentre, randomised, controlled, open-label, study comparing the efficacy and safety of slow repeated intravenous infusions of 2 doses of Doxorubicin TransdrugTM (DT) (20 mg/m² or 30 mg/m²) to th... | 2019-02-25 | due-trials |
| Exempt Terminated | 2011-005538-20 | SAFETY AND EFFICACY OF INTRAMUSCULAR ELECTROTRANSFER OF PLASMID AMEP IN PATIENTS SUFFERING FROM ADVANCED OR METASTATIC MELANOMA: AN OPEN-LABEL PHASE I/II CLINICAL TRIAL THE AIMM STUDY (AMEP IN METASTA... | 2013-10-02 | not-yet-due |